Tossing back in

Atossa Genetics Inc. refiled for an IPO and hopes to sell up to 3 million units at $5-$7, which would raise $18 million at a mid-point, in an offering on the NYSE Amex.

In March, the company had filed to raise up to $15 million on the OTC Bulletin Board, but withdrew the offering in July after concluding it was "no longer practicable."...